Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.12 PKR
833.46 M PKR
12.41 B PKR
78.86 M
About CITI PHARMA LIMITED
Sector
CEO
Rizwan Ahmad
Headquarters
Lahore
Website
Founded
2012
ISIN
PK0126201018
FIGI
BBG011LQGDH1
Citi Pharma Ltd. engages in the manufacturing and sale of pharmaceuticals, medical chemicals, and botanical products. Its products portfolio includes paracetamol, Penicillin/Amoxicillin, Levofloxacin, Cefixime/Cephalosporin, Ciprofloxacin, Cephradine, Norfloxacin, Aspirin, Ibuprofen, and Ascorbic Acid. The company was founded on October 8, 2012 and is headquartered in Lahore, Pakistan.
CPHL will be double in value soon. Positive momentum and maintaining
support of 62 today, It is likely to cross 81.25, 100 and 120 levels.
I think it could cross 120 level in
January of February 2025.
Note: this is not a buy/sell call
Use stop loss whenever trade.
CPHL - PSX - Technical AnalysisCiti Pharma is in bull run for almost past 9 months. On Monthly TF, Cup has been formed but Handle is yet to be made. See picture pasted on the chart. For that price must retrace a bit to Fib 0.23 to 0.38. In that case Entry will be at retrace and TP will be equal to depth of the cup.
On the other
CPHL-Buy CallAfter listing in PSX in 2021, the instrument posted high of around 50. After that it was in bearish trend and touched low of around 19. However, during last three years, the instrument made typical Cup and handle pattern and gave breakout with huge volume. Now it is in bullish trend and making HH an
CPHL continuing upward moveCPHL was in correction phase know showing bullish signs on daily char, current levels are good for buying .
CPHL | Cup & Handle PatternCPHL is currently forming a cup and handle pattern, with the cup already completed. The stock is expected to experience a pullback as it forms the handle, with the neckline situated around Rs. 35.67. Initial support for the handle is anticipated in the range of Rs. 31.70 to Rs. 31, where a long posi
CPHLPrice in up Trend forming HH, HL.
Price is consolidating for the upward move, as per Formation projection.
CPHLWait for the break out from resistance level other wise profit taking from resistance level is expected, and pull back from support. Keep an eye on it.
CPHL - BULL FLAG, TARGET: 35.20CPHL surpassed the 50% target at the 30.90 level and hit the upper cap at 31.59. The current momentum shows strong bullish behavior in the North, indicating that the target of 35.20 might be achieved in the next few sessions. It is suggested to stay long!
TARGET: 35.20
CPHL is BullishCPHL has given a breakout from the downward trend after bullish divergence appeared on RSI. It also successfully broke the previous lower high and printed a higher high indicating that bulls are taking control of the price action. If it forms a higher low, it could move up to new highs soon. Targets
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CPHL is 95.66 PKR — it has decreased by −0.33% in the past 24 hours. Watch CITI PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on PSX exchange CITI PHARMA LIMITED stocks are traded under the ticker CPHL.
CPHL stock has risen by 2.10% compared to the previous week, the month change is a 39.85% rise, over the last year CITI PHARMA LIMITED has showed a 314.11% increase.
CPHL reached its all-time high on Jan 31, 2025 with the price of 101.10 PKR, and its all-time low was 19.07 PKR and was reached on Sep 1, 2023. View more price dynamics on CPHL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CPHL stock is 3.68% volatile and has beta coefficient of 1.34. Track CITI PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is CITI PHARMA LIMITED there?
Yes, you can track CITI PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
CITI PHARMA LIMITED is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
CPHL net income for the last quarter is 201.50 M PKR, while the quarter before that showed 152.07 M PKR of net income which accounts for 32.51% change. Track more CITI PHARMA LIMITED financial stats to get the full picture.
Yes, CPHL dividends are paid annually. The last dividend per share was 3.25 PKR. As of today, Dividend Yield (TTM)% is 3.39%. Tracking CITI PHARMA LIMITED dividends might help you take more informed decisions.
CITI PHARMA LIMITED dividend yield was 11.40% in 2024, and payout ratio reached 89.09%. The year before the numbers were 11.72% and 86.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 7, 2025, the company has 615.00 employees. See our rating of the largest employees — is CITI PHARMA LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CITI PHARMA LIMITED EBITDA is 1.54 B PKR, and current EBITDA margin is 9.94%. See more stats in CITI PHARMA LIMITED financial statements.
Like other stocks, CPHL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CITI PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CITI PHARMA LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CITI PHARMA LIMITED stock shows the buy signal. See more of CITI PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.